Annals of Surgical Oncology

, Volume 19, Issue 9, pp 2908–2916 | Cite as

Impact of Obesity and Body Fat Distribution on Survival After Pancreaticoduodenectomy for Pancreatic Adenocarcinoma

  • Sébastien Gaujoux
  • Javiera Torres
  • Sara Olson
  • Corrine Winston
  • Mithat Gonen
  • Murray F. Brennan
  • David S. Klimstra
  • Michael D’Angelica
  • Ronald DeMatteo
  • Yuman Fong
  • Michael House
  • William Jarnagin
  • Robert C. Kurtz
  • Peter J. Allen
Hepatobiliary Tumors



Epidemiologic studies have reported a positive correlation between body mass index (BMI) and pancreatic cancer risk, but clinical relevance of obesity and/or body fat distribution on tumor characteristics and cancer-related outcome remain controversial. We sought to assess the influence of obesity and body fat distribution on pathologic characteristics and survival after pancreaticoduodenectomy for pancreatic adenocarcinoma.


Demographic and biometric data were collected on 328 patients undergoing pancreaticoduodenectomy for pancreatic ductal adenocarcinoma. In a subset of patients, pancreatic fatty infiltration and fibrosis were assessed pathologically, and visceral fat area (VFA) was evaluated. Influence of BMI and body fat distribution on tumor characteristics and survival were evaluated.


A significant positive correlation between BMI and VFA was observed, with a wide range of VFA value within each BMI class. According to BMI or VFA distribution, there were no significant differences in patient characteristics, intraoperative or perioperative outcome, or pathologic characteristics, with the exception of significantly higher blood loss in patients with an increased body weight or VFA. Unadjusted overall and disease-free survival between BMI class and VFA quartile were not significantly different.


In this study, obesity and body fat distribution were not correlated with specific tumor characteristics or cancer-related outcome.


Body Mass Index Pancreatic Cancer Pancreatic Adenocarcinoma Pancreatic Ductal Adenocarcinoma Pancreatic Cancer Risk 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



Sébastien Gaujoux was recipient of a grant from the European Society of Surgical Oncology (ESSO), the Association Française de Chirurgie Hépato-Biliaire et de Transplantation Hépatique (ACHBT).


None of the authors has any conflict of interest


  1. 1.
    Finucane MM, Stevens GA, Cowan MJ, et al. National, regional, and global trends in body-mass index since 1980: Systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9.1 million participants. Lancet. 2011;377(9765):557–67.PubMedCrossRefGoogle Scholar
  2. 2.
    Vital signs: state-specific obesity prevalence among adults—United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59:951–5.Google Scholar
  3. 3.
    Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.PubMedCrossRefGoogle Scholar
  4. 4.
    Larsson SC, Orsini N, Wolk A. Body mass index and pancreatic cancer risk: a meta-analysis of prospective studies. Int J Cancer. 2007;120:1993–8.PubMedCrossRefGoogle Scholar
  5. 5.
    Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer. 2004;4:579–91.PubMedCrossRefGoogle Scholar
  6. 6.
    Genkinger JM, Spiegelman D, Anderson KE, et al. A pooled analysis of 14 cohort studies of anthropometric factors and pancreatic cancer risk. Int J Cancer. 2011;129:1708–17.PubMedCrossRefGoogle Scholar
  7. 7.
    White PB, True EM, Ziegler KM, et al. Insulin, leptin, and tumoral adipocytes promote murine pancreatic cancer growth. J Gastrointest Surg. 2010;14:1888–93.PubMedCrossRefGoogle Scholar
  8. 8.
    Zyromski NJ, Mathur A, Pitt HA, et al. Obesity potentiates the growth and dissemination of pancreatic cancer. Surgery. 2009;146:258–63.PubMedCrossRefGoogle Scholar
  9. 9.
    Khasawneh J, Schulz MD, Walch A, et al. Inflammation and mitochondrial fatty acid beta-oxidation link obesity to early tumor promotion. Proc Natl Acad Sci U S A. 2009;106:3354–9.PubMedCrossRefGoogle Scholar
  10. 10.
    Li D, Morris JS, Liu J, et al. Body mass index and risk, age of onset, and survival in patients with pancreatic cancer. JAMA. 2009;301:2553–62.PubMedCrossRefGoogle Scholar
  11. 11.
    Fleming JB, Gonzalez RJ, Petzel MQ, et al. Influence of obesity on cancer-related outcomes after pancreatectomy to treat pancreatic adenocarcinoma. Arch Surg. 2009;144:216–21.PubMedCrossRefGoogle Scholar
  12. 12.
    Balentine CJ, Enriquez J, Fisher W, et al. Intra-abdominal fat predicts survival in pancreatic cancer. J Gastrointest Surg. 2010;14:1832–7.PubMedCrossRefGoogle Scholar
  13. 13.
    Khan S, Sclabas G, Reid-Lombardo K, et al. Does body mass index/morbid obesity influence outcome in patients who undergo pancreatoduodenectomy for pancreatic adenocarcinoma? J Gastrointest Surg. 2010;14:1820–5.PubMedCrossRefGoogle Scholar
  14. 14.
    Olson SH, Chou JF, Ludwig E, et al. Allergies, obesity, other risk factors and survival from pancreatic cancer. Int J Cancer. 2010;127:2412–9.PubMedCrossRefGoogle Scholar
  15. 15.
    Tsai S, Choti MA, Assumpcao L, et al. Impact of obesity on perioperative outcomes and survival following pancreaticoduodenectomy for pancreatic cancer: a large single-institution study. J Gastrointest Surg. 2010;14:1143–50.PubMedCrossRefGoogle Scholar
  16. 16.
    House MG, Fong Y, Arnaoutakis DJ, et al. Preoperative predictors for complications after pancreaticoduodenectomy: impact of BMI and body fat distribution. J Gastrointest Surg. 2008;12:270–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Grobmyer SR, Pieracci FM, Allen PJ, Brennan MF, Jaques DP. Defining morbidity after pancreaticoduodenectomy: use of a prospective complication grading system. J Am Coll Surg. 2007;204:356–64.PubMedCrossRefGoogle Scholar
  18. 18.
    Ammann RW, Heitz PU, Kloppel G. Course of alcoholic chronic pancreatitis: a prospective clinicomorphological long-term study. Gastroenterology. 1996;111:224–31.PubMedCrossRefGoogle Scholar
  19. 19.
    Gaujoux S, Cortes A, Couvelard A, et al. Fatty pancreas and increased body mass index are risk factors of pancreatic fistula after pancreaticoduodenectomy. Surgery. 2010;148:15–23.PubMedCrossRefGoogle Scholar
  20. 20.
    Guiu B, Petit JM, Bonnetain F, et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut. 2010;59:341–7.PubMedCrossRefGoogle Scholar
  21. 21.
    Physical status: The use and the interpretation of anthropometry: Report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;(854):1–452.Google Scholar
  22. 22.
    Larsson SC, Permert J, Hakansson N, Naslund I, Bergkvist L, Wolk A. Overall obesity, abdominal adiposity, diabetes and cigarette smoking in relation to the risk of pancreatic cancer in two Swedish population-based cohorts. Br J Cancer. 2005;93:1310–5.PubMedCrossRefGoogle Scholar
  23. 23.
    Arslan AA, Helzlsouer KJ, Kooperberg C, et al. Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan). Arch Intern Med. 2010;170:791–802.PubMedCrossRefGoogle Scholar
  24. 24.
    Kant P, Hull MA. Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer. Nat Rev Gastroenterol Hepatol. 2011;8:224–38.PubMedCrossRefGoogle Scholar
  25. 25.
    Ansary-Moghaddam A, Huxley R, Barzi F, et al. The effect of modifiable risk factors on pancreatic cancer mortality in populations of the Asia–Pacific region. Cancer Epidemiol Biomarkers Prev. 2006;15:2435–40.PubMedCrossRefGoogle Scholar
  26. 26.
    Berrington de Gonzalez A, Spencer EA, Bueno-de-Mesquita HB, et al. Anthropometry, physical activity, and the risk of pancreatic cancer in the European prospective investigation into cancer and nutrition. Cancer Epidemiol Biomarkers Prev. 2006;15:879–85.PubMedCrossRefGoogle Scholar
  27. 27.
    McWilliams RR, Matsumoto ME, Burch PA, et al. Obesity adversely affects survival in pancreatic cancer patients. Cancer. 2010;116:5054–62.PubMedCrossRefGoogle Scholar
  28. 28.
    Benns M, Woodall C, Scoggins C, McMasters K, Martin R. The impact of obesity on outcomes following pancreatectomy for malignancy. Ann Surg Oncol. 2009;16:2565–9.PubMedCrossRefGoogle Scholar
  29. 29.
    Riediger H, Keck T, Wellner U, et al. The lymph node ratio is the strongest prognostic factor after resection of pancreatic cancer. J Gastrointest Surg. 2009;13:1337–44.PubMedCrossRefGoogle Scholar
  30. 30.
    Chaston TB, Dixon JB. Factors associated with percent change in visceral versus subcutaneous abdominal fat during weight loss: findings from a systematic review. Int J Obes (Lond). 2008;32:619–28.CrossRefGoogle Scholar
  31. 31.
    Wirth A, Steinmetz B. Gender differences in changes in subcutaneous and intra-abdominal fat during weight reduction: an ultrasound study. Obes Res. 1998;6:393–9.PubMedGoogle Scholar
  32. 32.
    Kuk JL, Ross R. Influence of sex on total and regional fat loss in overweight and obese men and women. Int J Obes (Lond). 2009;33:629–34.CrossRefGoogle Scholar
  33. 33.
    Abate N. Insulin resistance and obesity. The role of fat distribution pattern. Diabetes Care. 1996;19:292–4.PubMedGoogle Scholar
  34. 34.
    Demerath EW, Reed D, Rogers N, et al. Visceral adiposity and its anatomical distribution as predictors of the metabolic syndrome and cardiometabolic risk factor levels. Am J Clin Nutr. 2008;88:1263–71.PubMedGoogle Scholar
  35. 35.
    Pou KM, Massaro JM, Hoffmann U, et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation. 2007;116:1234–41.PubMedCrossRefGoogle Scholar
  36. 36.
    Fox CS, Massaro JM, Hoffmann U, et al. Abdominal visceral and subcutaneous adipose tissue compartments: Association with metabolic risk factors in the Framingham Heart Study. Circulation. 2007;116:39–48.PubMedCrossRefGoogle Scholar
  37. 37.
    Weinsier RL, Hunter GR, Gower BA, Schutz Y, Darnell BE, Zuckerman PA. Body fat distribution in white and black women: Different patterns of intraabdominal and subcutaneous abdominal adipose tissue utilization with weight loss. Am J Clin Nutr. 2001;74:631–6.PubMedGoogle Scholar
  38. 38.
    Goodpaster BH. Measuring body fat distribution and content in humans. Curr Opin Clin Nutr Metab Care. 2002;5:481–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Mathur A, Zyromski NJ, Pitt HA, et al. Pancreatic steatosis promotes dissemination and lethality of pancreatic cancer. J Am Coll Surg. 2009;208:989–94.PubMedCrossRefGoogle Scholar
  40. 40.
    Dandona M, Linehan D, Hawkins W, Strasberg S, Gao F, Wang-Gillam A. Influence of obesity and other risk factors on survival outcomes in patients undergoing pancreaticoduodenectomy for pancreatic cancer. Pancreas. 2011;40:931–7.PubMedCrossRefGoogle Scholar
  41. 41.
    Mathur A, Hernandez J, Shaheen F, et al. Preoperative computed tomography measurements of pancreatic steatosis and visceral fat: prognostic markers for dissemination and lethality of pancreatic adenocarcinoma. HPB (Oxford). 2011;13:404–10.CrossRefGoogle Scholar
  42. 42.
    Ramsey AM, Martin RC. Body mass index and outcomes from pancreatic resection: a review and meta-analysis. J Gastrointest Surg. 2011;15:1633–42.PubMedCrossRefGoogle Scholar

Copyright information

© Society of Surgical Oncology 2012

Authors and Affiliations

  • Sébastien Gaujoux
    • 1
  • Javiera Torres
    • 2
  • Sara Olson
    • 3
  • Corrine Winston
    • 4
  • Mithat Gonen
    • 3
  • Murray F. Brennan
    • 1
  • David S. Klimstra
    • 2
  • Michael D’Angelica
    • 1
  • Ronald DeMatteo
    • 1
  • Yuman Fong
    • 1
  • Michael House
    • 1
  • William Jarnagin
    • 1
  • Robert C. Kurtz
    • 5
  • Peter J. Allen
    • 1
  1. 1.Department of SurgeryMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  2. 2.Department of PathologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  3. 3.Department of Biostatistics and EpidemiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  4. 4.Department of RadiologyMemorial Sloan-Kettering Cancer CenterNew YorkUSA
  5. 5.Department of Gastroenterology and NutritionMemorial Sloan-Kettering Cancer CenterNew YorkUSA

Personalised recommendations